Kazuyuki Mizuno

8PUBLICATIONS
18CO-AUTHORS
Immunogenetics (incl. genetic immunology)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsBiomedical imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 26, 2026
Vonoprazan is associated with a phenotype-specific increase in cholangitis reporting in immune checkpoint inhibitor-treated patients: a VigiBase pharmacovigilance study.

|Mar 08, 2026
FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel for Pancreatic Cancer by BRCA2 and TMB Status: A Japanese C-CAT Database Study.

Kazuyuki Mizuno, Takuya Ishikawa, Takanori Ito

|Dec 13, 2025
Efficacy and safety of immune checkpoint inhibitor rechallenge following immune-related adverse events: a review.

Kazuyuki Mizuno, Osamu Maeda, Yuichi Ando

|Jun 14, 2025
Safety and efficacy of retreatment with immune checkpoint inhibitors after severe immune-related adverse events.

Kazuyuki Mizuno, Takanori Ito, Tsunaki Sawada

|Jun 22, 2023
Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma.

Kazuyuki Mizuno, Norihiro Imai, Takafumi Yamamoto

|Feb 10, 2021
Bioinformatics and Functional Analyses Implicate Potential Roles for EOGT and L-fringe in Pancreatic Cancers.

Rashu Barua, Kazuyuki Mizuno, Yuko Tashima

Pageof 2

Frequent Collaborators

1 joint publications

Hidenori Toyoda

1 joint publications

Rashu Barua

1 joint publications

Mitsutaka Ogawa

1 joint publications

Hideyuki Takeuchi